A new antipsychotic drug: pimozide R 6238. Clinical evaluation
Fracassi, M.U.; Delvecchio, F.R.
Prensa Medica Argentina 58(28): 1444-1449
1971
ISSN/ISBN: 0032-745X PMID: 5166433 Document Number: 40283
Document emailed within 1 workday
Related Documents
Van Kammen, D.P.; Docherty, J.P.; Bunney, W.E. 1982: Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment Biological Psychiatry 17(2): 233-242Amery, W.; Boom, A.J.; Huisman, N.G.; Kuipers, H.; van der Wiel, H.J.; Reyntjens, A. 1972: A series of multicentric pilot trials with pimozide in psychiatric practice. IV. Pimozide in the treatment of patients with paranoid symptomatology Acta Psychiatrica Belgica 72(6): 677-684
Reyntjens, A.M. 1972: A series of multicentric pilot trials with pimozide in psychiatric practice. II. Pimozide in the treatment of behavioural disorders in childhood and adolescence Acta Psychiatrica Belgica 72(6): 662-670
Pöldinger, W. 1971: Clinical experience with pimozide Current Therapeutic Research 13(1): 23-27
Hirsch, S.R.; Link, C.G.; Goldstein, J.M.; Arvanitis, L.A. 1996: ICi 204,636: a new atypical antipsychotic drug British Journal of Psychiatry. Suppl 29: 45-56
McKenna, K.; Einarson, A.; Levinson, A.; Gideon, K. 2004: Significant changes in antipsychotic drug use during pregnancy Veterinary and Human Toxicology 46(1): 44-46
Zaleon, C.R.; Guthrie, S.K. 1994: Antipsychotic drug use in older adults American Journal of Hospital Pharmacy 51(23): 2917-2943; Quiz: 2959-2961
Elizur, A.; Steiner, M.; Davidson, S. 1979: Antipsychotic drug-induced paradoxical behavior Harefuah 96(10): 562-565
Rice, S. 2014: Nursing home cuts antipsychotic drug use Modern Healthcare 44(41): 27
Vergara, L.; Amin, M.M.; Ban, T.A. 1977: A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, Ii Psychopharmacology Bulletin 13(3): 17-19
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103
Zherdev, V.P.; Boĭko, S.S.; Mesonzhnik, N.V.; Appolonova, S.A.; Rodchenkov, G.N.; Ostrovskaia, R.U.; Gudasheva, T.A.; Seredenin, S.B. 2009: Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept Eksperimental'naia i Klinicheskaia Farmakologiia 72(3): 16-21
Scholten, M.R.M.; Selten, J.P. 2005: Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug Nederlands Tijdschrift Voor Geneeskunde 149(41): 2296-2298
Crane, T.; Dawson, C.M.; Tickner, T.R. 1993: False-positive results from the Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy Clinical Chemistry 39(3): 549
Meltzer, L.T.; Christoffersen, C.L.; Heffner, T.G.; Freeman, A.S.; Chiodo, L.A. 1989: CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity Journal of Pharmacology and Experimental Therapeutics 251(1): 123-130
Eren, E.; Ayşenur Yeğin; Yilmaz, N.; Herken, H. 2010: Serum Total Homocystein, Folate and Vitamin B12 Levels and their Correlation with Antipsychotic Drug Doses in Adult Male Patients with Chronic Schizophrenia Clinical Laboratory 56(11-12): 513-518
Cockburn, I. 1986: Cyclosporine A: a clinical evaluation of drug interactions Transplantation Proceedings 18(6 Suppl 5: 50-55
Trusov, V.V.; Pimenóv, L.T.; Guseva, L.P. 1975: Clinical evaluation of a spasmolytic drug, dimidin Vrachebnoe Delo 8: 30-34
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Baker, R.A.; Pikalov, A.; Tran, Q-Van.; Kremenets, T.; Arani, R.B.; Doraiswamy, P.Murali. 2009: Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis Psychopharmacology Bulletin 42(1): 11-31